Skip to main content

Table 3 Multiple linear regression analysis for the perinatal factors affecting cord blood cells characters

From: Umbilical cord blood cell characteristics in very preterm neonates for autologous cell therapy of preterm-associated complications

Cord blood cells characteristics

Cell concentration before processing*106/ml

Cord blood volume, ml

Cell viability,%

CD34% in MNCs

CFU-GM number/105

MNCs

P Value, OR (95% CI)

Antenatal glucocorticoids

0.005,-3.144(-5.312,-0.976)

0.493,-4.382,(-14.886,7.231)

0.073,-0.877(-1.837,0.083)

0.076,0.132(-0.014,0.277)

0.000,87.243(61.933,112.493)

Preeclampsia

0.007,-5.112(-8.781,-1.442)

0.954,0.546(-18.169,19.260)

0.512,-0.537(-2.162,1.088)

0.373,-0.111(-0.358,0.136)

0.188,-28.481(-71.213,14.251)

GA(weeks)

0.382,0.339(-0.429,1.108)

0.822,0.445(-3.475,4.365)

0.376,-0.152(-0.492,0.188)

0.030,-0.057(-0.109,-0.006)

0.032,-9.838(-18.789,-0.887)

  1. CS Caesarean section, GA Gestational age, kg Kilogram, CI Confidence interval, OR Odds ratio, CFU-GM Colony forming unit -granulocyte and macrophage, CD34 Cluster differentiation 34, MNCs Mononuclear cells, OR Odds ratio